Opinion

Video

Introducing the Expert Panel on CLL Treatment Updates Live at EHA 2024

Author(s):

Catherine C. Coombs, MDMatthew S. Davids, MD, MMSc

Key opinion leaders are introduced and present a concise overview of the topics to be addressed.

Related Videos
Alexey Danilov, MD, PhD
5 KOLs are featured in this program
5 KOLs are featured in this program
5 KOLs are featured in this panel.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Paolo Ghia, MD, PhD
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
2 KOLs are featured in this panel.
Related Content
Consuelo Bertossi, MD, of University Hospital Ulm in Germany
June 18th 2024

TP53 Mutations Are Associated With Unfavorable Prognosis in CLL

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Stephen Opat, of Monash Health
June 17th 2024

Sonrotoclax Plus Zanubrutinib Is Safe, Efficacious in Relapsed/Refractory CLL/SLL

Talal Hilal, MD, MB, BCh
January 12th 2023

Hilal Highlights BTK Inhibitor Research and Implications of MRD Negativity in CLL

William Wierda, MD, PhD
June 17th 2024

Lower Tumor Burden Associated With Improved ORR With Liso-Cel in R/R CLL/SLL

Adam Kittai, MD, of The Ohio State University
June 16th 2024

CD19-Directed CAR T-Cell Therapy Demonstrates Clinical Efficacy in Richter Transformation